Skip to content

TearLab Corp

Delisted

CIK 1299139fmd_0H4ZJKG5EHDVHBWHSR6JJW2JF1Manufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard

Coverage: Jan 01, 2009 to Mar 31, 2020, 41 periods

Income Statement · Annual · Millions · USD
Line itemFY2010FY2011FY2012FY2013FY2014FY2015FY2016FY2017FY2018FY2019
Total revenues22415202528272523
Cost of revenue12289111011––
Property operating expenses––011222––
Gross profit1026101316141614
Research and development1121375544
Selling, general and administrative56102230342521910
Total operating expenses891624354432261314
Operating income(7)(8)(12)(18)(25)(32)(16)(12)20
Interest expense00––––––56
Interest and investment income00000–––––
Other non-operating income (expense)0(1)(7)(11)1(2)(4)(4)(5)(6)
Income before taxes(7)(9)19292433201625
Income tax expense––000–––––
Net income from continuing operations––192924–––––
Net income(7)(9)(19)(29)(24)(33)(20)(16)(2)(5)
TearLab Corp financial statements · FinancialMD